Camp4 Therapeutics (CAMP) Net Equity Issued and Repurchased (2023 - 2024)
Camp4 Therapeutics (CAMP) reported Net Equity Issued and Repurchased of $76.3 million for Q4 2024, up 636100.0% on a YoY basis from N/an in Q1 2024, and up 246093.55% sequentially from $31000.0 in Q3 2024.
Camp4 Therapeutics (CAMP) Net Equity Issued and Repurchased (2023 - 2024) Analysis & Trends
Camp4 Therapeutics (CAMP) has 2 years of Net Equity Issued and Repurchased data on file, last reported at $76.3 million in Q4 2024.
- For the quarter ending Q4 2024, Net Equity Issued and Repurchased rose 636100.0% year-over-year to $76.3 million; the trailing twelve-month figure through Jun 2025 stood at $76.4 million (changed N/A YoY), and the FY2025 full-year result was $57.5 million, down 24.67% from the prior year.
- Net Equity Issued and Repurchased improved to $76.3 million in Q4 2024, from $31000.0 in the prior quarter.
- In the past five years, Net Equity Issued and Repurchased ranged from a high of $76.3 million in Q4 2024 to a low of -$12000.0 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 163.10 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 141.90 Mn |
| 10 | Camp4 Therapeutics | 174.35 Mn | 174.35 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 76.32 Mn |
| Dec 31, 2024 | 76.32 Mn |
| Sep 30, 2024 | 31,000.00 |
| Sep 30, 2024 | 31,000.00 |
| Mar 31, 2024 | 2,000.00 |
| Mar 31, 2024 | 2,000.00 |
| Dec 31, 2023 | -12,000.00 |
| Dec 31, 2023 | -12,000.00 |